Sex Reassignment Surgery (SRS) Market – By Gender Transition (Male to Female {Facial, Breast, Genitals [Phallectomy, Orchiectomy, Vaginoplasty]}, Female to Male {Facial, Chest, Genitals [Hysterectomy, Phalloplasty]}) & Global Forecast 2024 – 2032

Asia Cosmetic Hospital, Brigham and Womens Hospital, Kamol Hospital, Nirunda International Aesthetic Clinic, Phuket Plastic Surgery Institute, Rumer Cosmetic Surgery, Sava Perovic Foundation Surgery, Vancouver Coastal Health, Yanhee International Hospital, and Yeson Voice Center

North America sex reassignment surgery industry will register an 8.4% CAGR through 2032, driven by advanced healthcare infrastructure, increasing acceptance of transgender rights, and comprehensive insurance coverage.

Sex reassignment surgery industry size was USD 722.2 million in 2023 and will grow at 11.4% CAGR between 2024 and 2032, fueled by increased societal acceptance of transgender individuals, advancements in surgical techniques, and growing awareness of gender dysphoria.

The male to female segment garnered USD 369.9 million in 2023, attributed to a higher number of individuals seeking transition compared to female-to-male procedures.